CUTANEOUS LIMITED

Company Registration Number:
09930555 (England and Wales)

Unaudited micro entity accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

CUTANEOUS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

CUTANEOUS LIMITED

Company Information

for the Period Ended 31 December 2024




Registered office: 116
Station Road
Harpenden
England
AL5 4RH
Company Registration Number: 09930555 (England and Wales)

CUTANEOUS LIMITED

Profit and Loss Account

for the Period Ended 31 December 2024


2024
£

2023
£
Turnover 0 1,590
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 0 ) ( 0 )
Staff Costs ( 0 ) ( 0 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 67 ) ( 318 )
Tax on Profit ( 0 ) ( 317 )
Profit or (Loss) for Period ( 67 ) 955

CUTANEOUS LIMITED

Balance sheet

As at 31 December 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 18,844 23,640
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 18,844 23,640
Total assets less current liabilities: 18,844 23,640
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 18,844 23,640
Capital and reserves: 18,844 23,640

CUTANEOUS LIMITED

Balance sheet continued

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 September 2025
And Signed On Behalf Of The Board By:

Name: Dr Ajeet Bagga
Status: Director

The notes form part of these financial statements

CUTANEOUS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Employee Information

    Average number of employees: 0

CUTANEOUS LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Off balance sheet disclosure

    No